[Uric acid, the kidney and cardiovascular mortality]

Area of Science:

• Nephrology
• Cardiology
• Metabolic Diseases

Background:

• Hyperuricemia is a common metabolic alteration in chronic kidney disease (CKD).
• The precise impact of elevated uric acid on cardiovascular (CV) health, particularly within the CKD population, remains incompletely understood.
• While associations between uric acid and CV morbidity/mortality exist in the general population, its role as an independent risk factor is debated.

Purpose of the Study:

• To investigate the independent association between serum uric acid levels and cardiovascular events and mortality in patients with chronic kidney disease.
• To clarify the significance of hyperuricemia in the context of cardiovascular complications within the CKD population.

Main Methods:

• Analysis of data from the PIRP project (Prevention of Progressive Renal Failure of the Emilia-Romagna Region).
• Multivariate analysis was employed to assess the independent role of high uric acid levels.
• Evaluation of the correlation between serum uric acid levels and the occurrence of CV events and CV mortality.

Main Results:

• Elevated serum uric acid levels were found to be independently associated with an increased risk of cardiovascular events.
• High uric acid levels were also independently linked to a higher risk of cardiovascular mortality.
• These findings were observed even after accounting for other potential confounding factors through multivariate analysis.

Conclusions:

• Hyperuricemia plays an independent role in the development of cardiovascular morbidity and mortality in patients with chronic kidney disease.
• Serum uric acid levels should be considered a significant predictive factor for cardiovascular outcomes in the CKD population.
• Further research is warranted to explore the mechanisms underlying the link between hyperuricemia and cardiovascular disease in CKD.